172 related articles for article (PubMed ID: 2041583)
1. Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.
Coiro V; Chiodera P
Neuroendocrinology; 1991 Mar; 53(3):209-13. PubMed ID: 2041583
[TBL] [Abstract][Full Text] [Related]
2. Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men.
Coiro V; Capretti L; Speroni G; Castelli A; Bianconi L; Cavazzini U; Marcato A; Volpi R; Chiodera P
J Endocrinol Invest; 1990 Oct; 13(9):757-63. PubMed ID: 2292659
[TBL] [Abstract][Full Text] [Related]
3. Arginine vasopressin and oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men.
Chiodera P; Volpi R; Caiazza A; Giuliani N; Magotti MG; Coiro V
Metabolism; 1998 Aug; 47(8):893-6. PubMed ID: 9711980
[TBL] [Abstract][Full Text] [Related]
4. Gamma-aminobutyric acid mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking.
Chiodera P; Volpi R; Capretti L; Bocchi R; Caffarri G; Marcato A; Rossi G; Coiro V
Metabolism; 1993 Jun; 42(6):762-5. PubMed ID: 8510522
[TBL] [Abstract][Full Text] [Related]
5. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system.
Watanabe T; Oki Y; Orth DN
Endocrinology; 1989 Oct; 125(4):1921-31. PubMed ID: 2551632
[TBL] [Abstract][Full Text] [Related]
6. Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man.
Seckl JR; Johnson M; Shakespear C; Lightman SL
Clin Endocrinol (Oxf); 1988 May; 28(5):509-14. PubMed ID: 3214943
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin and oxytocin responses to hypertonic saline infusion: effect of the opioid antagonist naloxone.
Seckl JR; Johnson MR; Lightman SL
Clin Endocrinol (Oxf); 1989 May; 30(5):513-8. PubMed ID: 2605788
[TBL] [Abstract][Full Text] [Related]
8. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion.
Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J
Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231
[TBL] [Abstract][Full Text] [Related]
9. Opioid-mediated inhibition of oxytocin during insulin-induced hypoglycemic stimulation of vasopressin in man.
Seckl JR; Haddock JA; Dunne MJ; Lightman SL
Acta Endocrinol (Copenh); 1988 May; 118(1):77-81. PubMed ID: 2838996
[TBL] [Abstract][Full Text] [Related]
10. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by sodium valproate of the arginine vasopressin and adrenocorticotropin responses to angiotensin II in normal men.
Coiro V; Chiodera P
Brain Res; 1989 Jul; 491(1):169-72. PubMed ID: 2548660
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
Brain Res; 1986 Sep; 382(2):352-9. PubMed ID: 3756522
[TBL] [Abstract][Full Text] [Related]
14. Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits.
Fukuhara M; Matsumura K; Abe I; Fujishima M
Hypertens Res; 1998 Jun; 21(2):89-95. PubMed ID: 9661804
[TBL] [Abstract][Full Text] [Related]
15. Effect of aging on the arginine-vasopressin response to physostigmine and angiotensin II in normal men.
Chiodera P; Volpi R; Pilla S; Cataldo S; Capretti L; Coiro V
J Investig Med; 2000 May; 48(3):203-6. PubMed ID: 10822901
[TBL] [Abstract][Full Text] [Related]
16. Changes in oxytocin and vasopressin secretion during sexual activity in men.
Murphy MR; Seckl JR; Burton S; Checkley SA; Lightman SL
J Clin Endocrinol Metab; 1987 Oct; 65(4):738-41. PubMed ID: 3654918
[TBL] [Abstract][Full Text] [Related]
17. Different effects of the GABAergic agent sodium valproate on the oxytocin responses to angiotensin II and insulin-induced hypoglycemia in normal men.
Chiodera P; Coiro V
Horm Res; 1991; 36(1-2):27-31. PubMed ID: 1814797
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
Qadri F; Culman J; Veltmar A; Maas K; Rascher W; Unger T
J Pharmacol Exp Ther; 1993 Nov; 267(2):567-74. PubMed ID: 8246129
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neurohypophysial hormone secretion in an Australian marsupial.
Bathgate RA; Sernia C
Am J Physiol; 1995 May; 268(5 Pt 2):R1319-26. PubMed ID: 7771596
[TBL] [Abstract][Full Text] [Related]
20. Naloxone enhances angiotensin II-induced increase in serum luteinizing hormone concentrations in normal women.
Coiro V; Cigarini C; Volpi R; Capretti L; Bacchi-Modena A; Chiodera P
Regul Pept; 1994 May; 51(2):161-7. PubMed ID: 8059012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
